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Abstract 
Herpes simplex infection is characterized by acute or subacute infection, often followed 
by a chronic carrier state. Consecutive recurrences may flare up if immunocompromise 
occurs. Herpes simplex associated esophagitis or duodenal ulcer have been reported in 
immunocompromised patients due to neoplasm, HIV/AIDS or therapeutically induced 
immune deficiency. Here we report the case of an HSV-DNA seronegative patient who 
developed grade III dysphagia 13 days after allogeneic liver transplantation. Endoscopy 
revealed an esophageal-gastric ulcer, and biopsy histopathology showed a distinct 
fibroplastic and capillary ulcer pattern highly suspicious for viral infection. 
Immunohistochemistry staining revealed a distinct nuclear positive anti-HSV reaction. 
Antiviral therapy with acyclovir and high-dose PPI led to a complete revision of clinical 
symptoms within 48 h. Repeat control endoscopy after 7 days showed complete healing 
of the former ulcer site at the gastroesophageal junction. Although the incidence of 
post-transplantation Herpes simplex induced gastroesophageal disease is low, the viral 
HSV ulcer may be included into a differential diagnosis if dysphagia occurs after 
transplantation even if HSV-DNA PCR is negative. 
 
Introduction  
HSV infection is a well-known, chronic persistent viral infection of varying recurrence 
rate [1]. It has been reported that HSV can be the cause of esophagitis, as seen in 
immunodeficient patients under therapeutic immunosuppression [2, 3]. Although the 
risk of a HSV infection appears to be correlated to a degree of depression of the cellular  
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immune system, HSV infection is a rare condition after organ transplantation and 
consecutive immunosuppression therapy. HSV manifestations after transplantation have 
been described; however, usually a time delay between organ transplantation and HSV 
infection – corresponding with the time necessary for the achievement of full therapeutic 
immunosuppression – is seen. The herpes virus group consists of the Herpes zoster virus 
and the Herpes simplex virus [1, 4], the former occurring much more often as a painful 
post-transplant infection [5–7]. Infections or recurrences of HSV after transplantation are 
much more uncommon and comprise case reports describing esophagitis and nephritis 
[8, 9]. HSV manifestations as esophagitis are extremely rare; they have been seen in 
singular cases after kidney [8–10], liver [11], heart [12] and bone marrow transplant [13]. 
It was Itoh et al. who investigated the relationship between histopathological features and 
HSV associated esophagitis after transplantation. Reporting on 1,307 autopsies covering a 
10-year period, they detected a prevalence of 1.4% (14 out of 1,307) [7]. A HSV related 
ulcer of the gastroesophageal junction after transplantation has not been reported so far. 
We describe the very rare case of a seronegative Herpes simplex induced ulcer occurring 
in the early postoperative phase after liver transplantation. 
Case Report 
Patient History and Surgery 
A 64-year-old man with a cryptogenic Child Pugh C liver cirrhosis suffered from hepatic 
encephalopathy, massive ascites, splenomegaly and consecutive thrombocytopenia and anemia. Thus he 
underwent allogeneic orthotopic liver transplantation. It was realised by primary biliary anastomosis 
and temporary insertion of a biliary drain. 
On postoperative day 1 diffuse bleeding mandated relaparotomy, further complicated by systemic 
coagulopathy and transfusion requirements of 44 units of RPC, 118 units of FFP and 12 units of 
thrombocytes. A consecutive abdominal compartment syndrome and a hepatorenal syndrome 
necessitated haemodialysis for 5 days, during which programmed relaparotomies and abdominal 
washouts were performed. At day 10, the patient recovered without further sequelae and was transferred 
to the regular ward. Enteral feeding was started and increased to a full diet. At postoperative day 17 the 
patient reported dysphagia for liquids and solids without pain on swallowing, nausea and vomiting. On 
esophagogastroduodenoscopy a huge ulcer situated at the gastroesophageal junction was discovered as 
well as moderate gastritis with normal duodenum mucosa (fig. 1). 
Histopathology 
The histopathological examination of biopsies taken from the border and center of the ulcer showed 
epithelial lesions rich in fibroblasts and capillaries which were highly suspicious of viral infection. 
Additionally, there were fibrin deposits related to granular sites. The picture was enlarged by 
megacaryocytes with large lobulated nuclei showing milk glass foggy karyoplasm. On 
immunohistochemical analysis a distinct positive reaction for NTB-HSV antibodies was seen (fig. 2). 
Histopathological and immunohistochemical examinations showed a squamous cell epithelium with 
focal exasperated HSV loci without any sign of neoplasia. Immediate systemic antiviral therapy was 
started with acyclovir (15 mg/kg/day) plus high-dose PPI (esomeprazole) (50 mg twice a day) led to a 
complete remission of all clinical gastrointestinal symptoms within 48 h. The following course was 
uneventful; repeated endoscopy seven days later revealed a complete remission of the previous ulcer of 
the gastroesophageal junction. The patient was discharged in good health to the outpatient department 
with a good hepatorenal function.  
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Discussion 
HSV infection is a common and life-long infection; it may recur at any time as a 
reaction to different stimuli [1]. HSV-1 recurrences are more often described as 
compared to HSV-2 recurrences [14]. The possible association between HSV-1 infection 
and duodenal ulcer in immunocompromised patients has been described before [14]. Up 
to now, esophageal or esophagogastric ulcers following therapeutic immunosuppression 
have not yet been described. This is more than surprising, taking into account reports 
which describe HSV esophagitis after kidney transplantation [9], allogeneic liver 
transplantation [11], heart transplantation [12] and bone marrow transplantation [13]. As 
Bissig et al. [11] report HSV hepatitis 4 years after transplantation, it could be speculated 
that ulceration would occur during the same period mentioned. Nevertheless, we report 
the case of a HSV ulcer of the gastroesophageal junction 17 days after allogeneic liver 
transplantation, which was diagnosed by endoscopy, histopathology and 
immunohistochemistry. It is known that HSV infections can occur in 
immunocompromised patients and lead to concomitant seropositivity. While in these 
patients preventive acyclovir medication may be applied, our patient had not been 
diagnosed with HSV infection before and was HSV-PCR negative. Thus preventive 
acyclovir was not considered. Antiviral medication was started in our patient from the 
date of confirmation of the HSV infection on. 
In general, HSV reactivation can complicate the postoperative course of 
immunocompromised patients [12]. It has been known that patients with combined 
hepatorenal dysfunctions have an increased risk for reactivation of HSV [4]. Furthermore, 
CD4+/CD8+ depleted patients with liver cirrhosis have an increased risk for HSV 
recurrence [5–7]. Prophylactic antiviral medication can be chosen at least in patients at 
risk for CMV infection. Late infectious sequelae may thus be avoided, while costs and 
drug side effects may simultaneously increase. 
In our patient we report the early postoperative reactivation of HSV, leading to ulcer in 
an uncommon place. This might be due to a combination of hepatorhinorrhagia and 
massive transfusion which may have led to profound immunosuppression in our patient, 
although therapeutic immunosuppression was shown to be within therapeutic range. The 
massive bleeding may have led to the depletion of CD4+/CD8+ cells in our patient, which 
further added to the immunocompromised state. It cannot be excluded that 
intraoperative hypotension and systemic catecholamine application added to a mucosal 
hypoperfusion state with impaired microcirculation, thus increasing the vulnerability of 
the gastroesophageal junction. This may have led to a locally reduced immune 
surveillance in the gastrointestinal tract, which is regularly exposed to local 
microtraumata and infectious agents. We could not identify any causative factor leading 
to the lesion in the esophagus – nor elsewhere in the gastrointestinal tract. 
It is not known whether H2 blocking agents improve the healing in uncomplicated 
HSV ulcers. We feel that especially patients on steroids need mucous protection, thus the 
drug doses of PPI were doubled with diagnosis of HSV ulcer. Nevertheless, despite 
massive transfusion, immunocompromised situation and programmed relaparotomies, 
the patient recovered without sequelae, even in terms of immunocompetence. The single 
ulcer found at the gastroesophageal junction was the only expression of HSV reactivation. 
No further systemic complications occurred. 
It was macroscopically impossible to deduce the HSV infection from the ulcer 
visualized on endoscopy. Astonishingly polymerase chain reaction revealed a negative  
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serum anti-HSV titre pre- and postoperatively. Thus the herpes ulcer diagnosis was made 
by immunhistochemistry of the biopsy specimen alone. 
This case report demonstrates that even in the early postoperative phase after 
transplantation, HSV ulcer of the gastroesophageal junction can occur. Herpes ulcer, 
although very uncommon, must be added to the differential diagnosis in early 
postoperative ulcers of the gastroesophageal junction in immunocompromised patients. 
Fast diagnosis and targeted therapy may lead to a full and unproblematic recovery, as seen 
in this patient. As it may be difficult to confirm a HSV lesion by serum sample analysis 
alone, we recommend to take a biopsy specimen for further immunhistochemistry. 
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Fig. 1. First diagnostic proof of HSV induced lesion. 
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Fig. 2. Immunohistology staining with anti HSV antibodies reveals potent spots within esophageal 
squamous cells (red areas); 1:400 magnification. 
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